Spastin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{infobox-protein
| protein_name = Spastin
| gene = SPAST
| uniprot_id = Q9UBU2
| pdb_ids = 3E45, 3TW8, 4Y0M
| molecular_weight = ~66000 Da (isoform 1)
| subcellular_localization = Cytoplasm, Microtubules, Nuclear envelope
| protein_family = AAA ATPase (ATPases Associated with diverse cellular Activities)
}}
Spastin is a AAA ATPase protein encoded by the SPAST gene. Spastin is a microtubule-severing enzyme critical for cytoskeletal dynamics, axonal transport, and endosomal trafficking. Mutations in SPARST cause hereditary spastic paraplegia (SPG4), the most common form of autosomal dominant HSP.
| Domain | Residues | Function |
|---|---|---|
| MIT domain | 1-80 | Microtubule interaction |
| Linker region | 81-188 | Flexible tether |
| AAA ATPase domain | 299-560 | ATP hydrolysis, severing activity |
| Transmembrane region | 561-583 | Membrane association |
Spastin severs microtubules through ATP hydrolysis:
| Function | Mechanism |
|---|---|
| Axonal transport | Maintains microtubule tracks |
| Endosomal trafficking | Regulates endosomal morphology |
| Nuclear envelope | Maintains nuclear membrane integrity |
| Autophagy | Involved in autophagosome formation |
| Synaptic function | Presynaptic terminal organization |
| Aspect | Details |
|---|---|
| Inheritance | Autosomal dominant |
| Prevalence | ~40% of autosomal dominant HSP |
| Mechanism | Loss of function, haploinsufficiency |
| Onset | Variable, can be childhood to adult |
Pathogenic Mechanisms:
Some SPAST mutations cause ALS-like phenotype:
| Strategy | Status | Description |
|---|---|---|
| Gene therapy | Preclinical | AAV-SPAST delivery |
| Microtubule stabilizers | Research | Taxol, epothilone derivatives |
| ASO therapy | Research | Allele-specific silencing |
| Mitochondrial protectants | Research | CoQ10, antioxidants |
Hazan J, et al. (1999). "Spastin mutated in hereditary spastic paraplegia." Nat Genet 23(3):296-303. PMID:10645978
Errico A, et al. (2002). "Spastin in axonal outgrowth." EMBO J 21(12):3155-3165. PMID:12065421
Roll-Mecak A, et al. (2008). "The mechanism of microtubule severing by spastin." Nature 451(7176):363-367. PMID:18202662
Zhang C, et al. (2019). "Spastin deficiency and mitochondrial dysfunction." Acta Neuropathol Commun 7(1):222. PMID:31856877
Martignoni M, et al. (2021). "Spastin mutations: genotype-phenotype." J Neurol Sci 429:118028. PMID:34598012
Parker SG, et al. (2020). "Spastin AAA+ ATPase in health and disease." Cell Mol Life Sci 77(23):4851-4870. PMID:32889576
Solowska JM, et al. (2018). "Spastin in microtubule dynamics." Mol Neurobiol 55(9):7370-7382. PMID:29368182
Charvin D, et al. (2022). "Therapeutic approaches for HSP." Neurology 99(7):287-298. PMID:35851582
The study of Spastin Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.